Related Experiment Video
Updated: Apr 23, 2026

11:28
3D Microtissues for Injectable Regenerative Therapy and High-throughput Drug Screening
Published on: October 4, 2017
9.6K
Cell-embedded microgels as emerging miniature 3D tissue-mimics toward biochip-based toxicity screening
Margaux Delafosse1,2, Estelle Regnault1,2, Jasmin Gebauer-Barrett1,3
1KIST Europe Forschungsgesellschaft mbH Saarbrücken Germany.
Bioengineering & Translational Medicine
|April 22, 2026
Summary
Three-dimensional (3D) microgel scaffolds create realistic cell niches for advanced toxicity testing. These bioengineered systems offer novel in vitro screening tools for drug discovery and alternatives to animal testing.
Area of Science:
- Biotechnology
- Biomaterials Science
- Toxicology
Background:
- Advancements in synthetic 3D gel microenvironments enable bioengineered organ-specific cell niches.
- 3D cell cultures using hydrogel scaffolds are increasingly used for toxicological analyses.
- These systems offer facile adaptability to on-chip applications as in vitro screening tools.
Purpose of the Study:
- To summarize progress in microgel-based 3D cell cultures integrated into biochip platforms.
- To review their utilization for in vitro toxicity evaluation of chemicals and drug candidates.
- To highlight tissue-mimicking microgel systems combined with automated chips and organ-on-a-chip devices.
Main Methods:
- Encapsulation of mammalian cells within microscale hydrogel scaffolds.
- Development of tissue-mimicking microgel systems.
- Integration of microgel systems with automated gel microarray chips and organ-on-a-chip devices.
Main Results:
- Microgel-based 3D cell cultures provide in vitro tissue mimicry.
- These systems are effective for toxicity testing and screening of chemicals and drug candidates.
- Technical advantages are noted for drug discovery and as alternatives to animal testing.
Conclusions:
- Microgel-based 3D cell cultures in biochip platforms represent a significant advancement in in vitro toxicity evaluation.
- These tissue-mimicking systems offer a promising avenue for efficient drug discovery and reducing animal testing.
- The integration of microgels with organ-on-a-chip technology is key to developing next-generation screening tools.

